SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-015256
Filing Date
2022-08-08
Accepted
2022-08-08 08:11:21
Documents
63
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q crsp-20220630.htm   iXBRL 10-Q 2618886
2 EX-10.1 crsp-ex10_1.htm EX-10.1 156728
3 EX-10.2 crsp-ex10_2.htm EX-10.2 14451
4 EX-31.1 crsp-ex31_1.htm EX-31.1 14394
5 EX-31.2 crsp-ex31_2.htm EX-31.2 14400
6 EX-32.1 crsp-ex32_1.htm EX-32.1 13613
  Complete submission text file 0000950170-22-015256.txt   9443809

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crsp-20220630.xsd EX-101.SCH 43129
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crsp-20220630_def.xml EX-101.DEF 166493
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crsp-20220630_pre.xml EX-101.PRE 277783
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crsp-20220630_cal.xml EX-101.CAL 48067
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crsp-20220630_lab.xml EX-101.LAB 386084
57 EXTRACTED XBRL INSTANCE DOCUMENT crsp-20220630_htm.xml XML 2061795
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37923 | Film No.: 221142635
SIC: 2836 Biological Products, (No Diagnostic Substances)